Inpharma Russia Information

The Russian pharmaceutical market is a great opportunity, but only with the right partner The Russian Pharmaceutical market shows great prospective over the next 5-10 years. With a forecasted annual turnover expected to double, from 20bn to 45bn USD by 2020, the Russian market offers a truly rich potential to any foreign manufacturers, but expertise is crucial. However, setting up pharmaceutical operations in Russia is a challenging task, and expertise is crucial. Besides language and behavioral barriers, complex pharmaceutical legislation and regulation, as well as an incessant bureaucracy, a volatile environment, and lack of reliable quantitative data can all expose the manufacturer to serious obstacles on their way to success. Local insight is key to the development of effective and legal entry into market, as well as the choice of local partners and efficient deployment of a representative structure. We offer all of this, either in-house, or through the help of trustworthy local partners. We operate in Russia from our office in Moscow, but thanks to the recent development of the Custom Union Zone, we can provide effective solutions in Kazakhstan and Belarus. Nevertheless, trading across pharmaceuticals, InPharma has a deep focus in preserving its business Ethics and Values to the highest industry standards. Last but not least, thanks to its international team, InPharma is able to dialogue with you fluently in English, Russian and Italian, and there is also the possibility to support your needs in other additional languages (among them as a matter of example: Chinese Mandarin, Korean and Spanish). Please explore our services, expertise and case studies, and feel free to contact us, for any given matters – One of our members will pick your query according to its expertise and come back to you.